+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Office Based Labs Market - Global Forecast 2026-2032- Product Image
Office Based Labs Market - Global Forecast 2026-2032- Product Image
New

Office Based Labs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5470716
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As healthcare demands evolve, the office-based labs market is rapidly adapting to meet provider needs for agile, effective diagnostic solutions. Senior decision-makers face a complex landscape shaped by shifting care models, regulatory pressures, and accelerated adoption of automation and advanced laboratory technologies.

Market Snapshot: Office-Based Labs Market

The office-based labs market expanded from USD 54.16 billion in 2025 to USD 57.92 billion in 2026 and is projected to achieve strong growth, reaching USD 99.53 billion by 2032 with a CAGR of 9.08%. This sustained expansion is driven by major sector trends including the rise in outpatient diagnostics, broader adoption of advanced laboratory equipment, and a growing emphasis on timely, point-of-care clinical decision support.

Scope & Segmentation of the Office-Based Labs Market

  • Technology Types: Clinical chemistry analyzers (continuous flow and discrete models), coagulation and hemostasis platforms (including platelet function testing and prothrombin time), hematology analyzers, immunoassay systems such as chemiluminescence and enzyme-linked techniques, and molecular diagnostics technologies like PCR, FISH, and next-generation sequencing.
  • Test Types: Point-of-care tests such as glucose and lipid screens, routine panels for chronic disease monitoring and preventive assessment, and specialized diagnostics including biomarker and genetic assays for precision medicine initiatives.
  • Product Categories: Automated analyzers in both standalone and integrated formats, next-generation sequencing platforms, and point-of-care devices available as benchtop or handheld solutions.
  • Clinical Applications: Acute and chronic disease management, infectious disease diagnostics, oncology-focused testing, and preventive screenings that support cardiovascular and metabolic risk management across varied patient populations.
  • End-User Segmentation: Hospital outreach laboratories, independent reference laboratories, and physician office laboratories, each characterized by unique operational priorities, procurement processes, and patient care delivery models.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific. Regions reflect local regulatory guidance, reimbursement climates, technology adoption rates, and infrastructure investment levels that influence purchasing and implementation strategies.

Key Takeaways for Senior Decision-Makers

  • Modernizing laboratory operations with automation and integrated informatics is improving turnaround times and supporting more reliable diagnostics within office-based lab settings.
  • As decentralization progresses, demand grows for compact, easy-to-integrate solutions that deliver results directly at the point of care, requiring procurement and workflow flexibility.
  • Effective management of increased test complexity relies on cross-trained personnel, scalable systems, and continuous quality assurance practices responsive to evolving diagnostic menus.
  • Molecular and immunoassay technology innovation is expanding available testing options and enabling more personalized diagnostics; however, successful deployment depends on robust integration and procurement planning.
  • Vendors offering robust interoperability, smooth onboarding, and service contracts aligned with customer goals are better positioned for lasting relationships in a competitive market.
  • Successful lab strategies now hinge on coordinated adaptation to clinical trends, regulatory updates, and operational shifts that drive investment and partnership decisions.

Tariff Impact: Supply Chain and Cost Management

Recent tariff adjustments have prompted new procurement strategies, motivating laboratories and vendors to strengthen supply chain resilience and enhance total cost management. Efforts include greater sourcing diversification, nearshoring initiatives, transparent inventory controls, and standardized consumables to reduce exposure to pricing volatility. Suppliers responding with flexible pricing models and improved post-sale support build stronger trust as regulatory landscapes evolve.

Methodology & Data Sources

This report is built on primary interviews with laboratory executives, procurement specialists, clinicians, and industry leaders. Conclusions are validated through regulatory documentation, published research, and scenario analysis, ensuring actionable, real-world guidance for strategic planning in office-based labs.

Why This Report Matters

  • Empowers evidence-based procurement, guiding technology investments to align with shifting clinical and operational priorities in the office-based labs sector.
  • Enables executive teams to mitigate risks in supply chain management and compliance while harnessing innovation to improve both performance and patient care.
  • Provides strategic clarity on adapting to diverse regional dynamics and integrating best practices for sustainable growth across global laboratory environments.

Conclusion

The continued evolution of office-based laboratories hinges on adaptive technology adoption, strong workforce strategies, and resilient supply chain practices. Decision-makers who champion integration and collaboration will deliver long-term value in modern diagnostic care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Office Based Labs Market, by Technology Type
8.1. Clinical Chemistry
8.1.1. Continuous Flow
8.1.2. Discrete Analyzers
8.2. Coagulation & Hemostasis
8.2.1. Platelet Function Testing
8.2.2. Prothrombin Time INR
8.3. Hematology
8.3.1. Automated Hematology Analyzers
8.3.2. Manual Cell Counters
8.4. Immunoassay
8.4.1. Chemiluminescence
8.4.2. Enzyme-Linked Immunoassay
8.5. Molecular Diagnostics
8.5.1. Fluorescence In Situ Hybridization
8.5.2. Next-Generation Sequencing
8.5.3. Polymerase Chain Reaction
9. Office Based Labs Market, by Test Type
9.1. Point-of-Care Tests
9.1.1. Glucose Monitoring
9.1.2. Lipid Testing
9.2. Routine Tests
9.2.1. Basic Panels
9.2.2. Comprehensive Panels
9.3. Specialized Tests
9.3.1. Biomarker Tests
9.3.2. Genetic Tests
10. Office Based Labs Market, by Product Type
10.1. Automated Analyzers
10.1.1. Discrete
10.1.2. Integrated
10.2. Next-Generation Sequencing
10.2.1. Targeted Panel Sequencing
10.2.2. Whole Genome Sequencing
10.3. Point-of-Care Devices
10.3.1. Benchtop
10.3.2. Handheld
11. Office Based Labs Market, by Application
11.1. Disease Monitoring
11.1.1. Acute Condition Monitoring
11.1.2. Chronic Disease Monitoring
11.2. Healthcare Diagnostics
11.2.1. Infectious Diseases
11.2.2. Oncology Diagnostics
11.3. Preventive Screening
11.3.1. Cardiovascular Screening
11.3.2. Metabolic Screening
12. Office Based Labs Market, by End User
12.1. Hospital Outreach Laboratories
12.2. Independent Reference Laboratories
12.3. Physician Office Laboratories
13. Office Based Labs Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Office Based Labs Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Office Based Labs Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Office Based Labs Market
17. China Office Based Labs Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Abionic SA
18.7. ARKRAY, Inc.
18.8. Beckman Coulter, Inc.
18.9. Becton, Dickinson and Company
18.10. bioMérieux SA
18.11. Boule Diagnostics
18.12. Danaher Corporation
18.13. EKF Diagnostics Holdings plc
18.14. F. Hoffmann-La Roche Ltd
18.15. Ortho Clinical Diagnostics Inc.
18.16. QIAGEN N.V.
18.17. Siemens Healthineers AG
18.18. STRATEC SE
18.19. Sysmex Corporation
18.20. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL OFFICE BASED LABS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL OFFICE BASED LABS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL OFFICE BASED LABS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL OFFICE BASED LABS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL OFFICE BASED LABS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES OFFICE BASED LABS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA OFFICE BASED LABS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL OFFICE BASED LABS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PLATELET FUNCTION TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PLATELET FUNCTION TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PLATELET FUNCTION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PROTHROMBIN TIME INR, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PROTHROMBIN TIME INR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PROTHROMBIN TIME INR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED HEMATOLOGY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED HEMATOLOGY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MANUAL CELL COUNTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MANUAL CELL COUNTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MANUAL CELL COUNTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHEMILUMINESCENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHEMILUMINESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL OFFICE BASED LABS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL OFFICE BASED LABS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL OFFICE BASED LABS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL OFFICE BASED LABS MARKET SIZE, BY LIPID TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL OFFICE BASED LABS MARKET SIZE, BY LIPID TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL OFFICE BASED LABS MARKET SIZE, BY LIPID TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BASIC PANELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BASIC PANELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BASIC PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COMPREHENSIVE PANELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COMPREHENSIVE PANELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL OFFICE BASED LABS MARKET SIZE, BY COMPREHENSIVE PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BIOMARKER TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BIOMARKER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OFFICE BASED LABS MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISCRETE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TARGETED PANEL SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TARGETED PANEL SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL OFFICE BASED LABS MARKET SIZE, BY TARGETED PANEL SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL OFFICE BASED LABS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL OFFICE BASED LABS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL OFFICE BASED LABS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BENCHTOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL OFFICE BASED LABS MARKET SIZE, BY BENCHTOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ACUTE CONDITION MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ACUTE CONDITION MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ACUTE CONDITION MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL OFFICE BASED LABS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CARDIOVASCULAR SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CARDIOVASCULAR SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL OFFICE BASED LABS MARKET SIZE, BY CARDIOVASCULAR SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL OFFICE BASED LABS MARKET SIZE, BY METABOLIC SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL OFFICE BASED LABS MARKET SIZE, BY METABOLIC SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL OFFICE BASED LABS MARKET SIZE, BY METABOLIC SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HOSPITAL OUTREACH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HOSPITAL OUTREACH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL OFFICE BASED LABS MARKET SIZE, BY HOSPITAL OUTREACH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL OFFICE BASED LABS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL OFFICE BASED LABS MARKET SIZE, BY PHYSICIAN OFFICE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL OFFICE BASED LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS OFFICE BASED LABS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. EUROPE OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. EUROPE OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 242. EUROPE OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPE OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 244. EUROPE OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 245. EUROPE OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 246. EUROPE OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 247. EUROPE OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 248. EUROPE OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 250. EUROPE OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 251. EUROPE OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. EUROPE OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 253. EUROPE OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 254. EUROPE OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 255. EUROPE OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. EUROPE OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 257. EUROPE OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 258. EUROPE OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 259. EUROPE OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. AFRICA OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 281. AFRICA OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 282. AFRICA OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 283. AFRICA OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 284. AFRICA OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 285. AFRICA OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 286. AFRICA OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 287. AFRICA OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 288. AFRICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 289. AFRICA OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 290. AFRICA OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 291. AFRICA OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 292. AFRICA OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 293. AFRICA OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 294. AFRICA OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 295. AFRICA OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 296. AFRICA OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 297. AFRICA OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 298. AFRICA OFFICE BASED LABS MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
TABLE 299. AFRICA OFFICE BASED LABS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 306. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 308. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2032 (USD MILLION)
TABLE 309. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY ROUTINE TESTS, 2018-2032 (USD MILLION)
TABLE 310. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY SPECIALIZED TESTS, 2018-2032 (USD MILLION)
TABLE 311. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 312. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY AUTOMATED ANALYZERS, 2018-2032 (USD MILLION)
TABLE 313. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 314. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY POINT-OF-CARE DEVICES, 2018-2032 (USD MILLION)
TABLE 315. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 316. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY DISEASE MONITORING, 2018-2032 (USD MILLION)
TABLE 317. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY HEALTHCARE DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 318. ASIA-PACIFIC OFFICE BASED LABS MARKET SIZE, BY PR

Companies Mentioned

The key companies profiled in this Office Based Labs market report include:
  • Abbott Laboratories
  • Abionic SA
  • ARKRAY, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Boule Diagnostics
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd
  • Ortho Clinical Diagnostics Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • STRATEC SE
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 57.92 Billion
Forecasted Market Value ( USD ) by 2032 $ 99.53 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Office-based Labs Market - Global Strategic Business Report - Product Image

Office-based Labs Market - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Primary Care PoC Diagnostics Market Size, Share & Trends Analysis Report By Disease (Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Primary Care PoC Diagnostics Market Size, Share & Trends Analysis Report By Disease (Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Single Specialty, Multi-Specialty), By Service (Cardiac, Endovascular Intervention, Venous), By Specialist, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Single Specialty, Multi-Specialty), By Service (Cardiac, Endovascular Intervention, Venous), By Specialist, And Segment Forecasts, 2025 - 2033

  • Report
  • 100 Pages
  • United States
From
Physician Office Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Physician Office Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Physician Office Diagnostics - Global Strategic Business Report - Product Image

Physician Office Diagnostics - Global Strategic Business Report

  • Report
  • 299 Pages
  • Global
From

About the Office Based Lab Market

The Office Based Lab (OBL) market is a subset of the in-office testing market, which focuses on providing laboratory services within a physician's office. OBLs provide a range of services, including clinical chemistry, hematology, immunology, and molecular diagnostics. These services are typically used to diagnose and monitor a variety of conditions, such as diabetes, heart disease, and infectious diseases. OBLs are typically equipped with the necessary equipment and supplies to perform tests, as well as trained personnel to interpret the results. OBLs offer a number of advantages over traditional laboratory services, including improved patient convenience, faster turnaround times, and cost savings. Additionally, OBLs can provide physicians with more timely and accurate information to help them make better decisions about patient care. Some companies in the OBL market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.